Scientific publications

Multidisciplinary Consensus for the Management of Pulmonary Thromboembolism

Feb 13, 2022 | Magazine: Archivos de Bronconeumología

José Luis Lobo  1 , Sergio Alonso  2 , Juan Arenas  3 , Pere Domènech  4 , Pilar Escribano  5 , Carmen Fernández-Capitán  6 , Luis Jara-Palomares  7 , Sonia Jiménez  8 , María Lázaro  9 , Ramón Lecumberri  10 , Manuel Monreal  11 , Pedro Ruiz-Artacho  12 , David Jiménez  13 , en nombre del Panel Multidisciplinar para el Manejo de la TEP


We have updated recommendations on 12 controversial topics that were published in the 2013 National Consensus on the diagnosis, risk stratification and treatment of patients with pulmonary embolism (PE).

A comprehensive review of the literature was performed for each topic, and each recommendation was evaluated in two teleconferences. For diagnosis, we recommend against using the Pulmonary Embolism Rule Out Criteria (PERC) rule as the only test to rule out PE, and we recommend using a D-dimer cutoff adjusted to age to rule out PE.

We suggest using computed tomography pulmonary angiogram as the imaging test of choice for the majority of patients with suspected PE.

We recommend using direct oral anticoagulants (over vitamin K antagonists) for the vast majority of patients with acute PE, and we suggest using anticoagulation for patients with isolated subsegmental PE.

We recommend against inserting an inferior cava filter for the majority of patients with PE, and we recommend using full-dose systemic thrombolytic therapy for PE patients requiring reperfusion. The decision to stop anticoagulants at 3 months or to treat indefinitely mainly depends on the presence (or absence) and type of risk factor for venous thromboembolism, and we recommend against thrombophilia testing to decide duration of anticoagulation.

Finally, we suggest against extensive screening for occult cancer in patients with PE.

CITATION  Arch Bronconeumol. 2021 Feb 13;S0300-2896(21)00056-9.  doi: 10.1016/j.arbres.2021.01.031